News Daily News Weight Regained Within 18 Months of Stopping GLP-1 Drugs Michael O'Riordan January 08, 2026
News Daily News Cardiac Damage Starts Early When There’s Family History of Cardiometabolic Disease Caitlin E. Cox December 18, 2025
News Daily News Half of Patients Stop Semaglutide for Weight Loss by 1 Year Todd Neale September 18, 2025
News Daily News Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks Michael O'Riordan August 01, 2025
News Daily News Newer Weight-Loss Drugs Not Cost-effective at Current Prices Michael O'Riordan March 18, 2025
News Daily News Misleading Statements Common in Online Ads for Compounded GLP-1s L.A. McKeown January 20, 2025
News Daily News Global Commission Proposes ‘Radical’ Overhaul of Obesity Diagnosis L.A. McKeown January 14, 2025
News Daily News Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates L.A. McKeown January 10, 2025
News Daily News Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key Todd Neale November 13, 2024
News Daily News Defying Earlier GLP-1 Data, Study in Teens Sees Possible Mental Health Gains L.A. McKeown October 22, 2024
News Daily News Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits Michael O'Riordan October 03, 2024
News Daily News ‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database Michael O'Riordan August 21, 2024
News Daily News Tirzepatide Provides Sustained BP Reduction in Overweight Adults Todd Neale August 15, 2024
News Daily News Schoolwide Intervention May Improve Obesity Outcomes Over Time Yael L. Maxwell July 29, 2024
News Daily News ‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD Todd Neale June 27, 2024
News Daily News One in Three Overweight MI Patients May Benefit From Semaglutide Todd Neale February 26, 2024